Skip to content
Back to Guavy Wire
Stocks

Mangione Trial Set for September Amid Concerns Over Juror Safety

Instruments
UNH
Share

The trial of Luigi Mangione is set to begin in September, with jurors' identities remaining anonymous due to concerns about potential harassment or intimidation.

Mangione, 28, is accused of shooting UnitedHealthcare CEO Brian Thompson outside a hotel in Manhattan in December 2024. The killing sparked widespread condemnation and became emblematic of Americans' frustration with the health insurance industry's practices.

Prosecutors say they have evidence including hundreds of hours of surveillance video, fingerprints, DNA, a cellphone, a gun with matching ballistics, and a notebook allegedly containing Mangione's writings about hating insurers and wanting to kill.

More on Stocks

Disclaimer: Guavy is a data and market intelligence provider, not an investment advisor. The information, signals, and market analysis provided by the Guavy API and related services are for informational purposes only and are not intended as financial advice, investment recommendations, or an endorsement of any particular trading strategy. Trading in volatile markets, including cryptocurrency, carries significant risk and may not be suitable for all investors. Past performance is not indicative of future results. Users should consult with a qualified financial professional before making any investment decisions. Guavy makes no guarantee of trading profits or financial returns.

Market sentiment intelligence for apps, funds & agents

Location

729 55 Ave SW
Calgary AB T2V 0G4
Canada

© 2026 Guavy Inc